Zdrowie i gospodarka · 22/09/2014
FDA Releases Revised Draft Guidance for Estradiol Vaginal Cream Bioequivalence Studies
The Food and Drug Administration (FDA) has released a revised draft guidance for industry on estradiol vaginal cream, providing recommendations for bioequivalence studies to support abbreviated new drug applications (ANDAs).
Source: Federal Register — Food and Drug AdministrationOpen original release →